For: | Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6): 104-113 [PMID: 34904048 DOI: 10.4331/wjbc.v12.i6.104] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v12/i6/104.htm |
Number | Citing Articles |
1 |
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's disease. European Journal of Pharmacology 2023; 939: 175426 doi: 10.1016/j.ejphar.2022.175426
|
2 |
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda. A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative Disorders. Metabolites 2022; 12(11): 1052 doi: 10.3390/metabo12111052
|
3 |
Oytun Erbas, İlknur Altuntaş, Pemra Nesil, Hadi Sasani, Mehtap Odabaşı. Translational Neuroprotection - The Way Ahead [Working Title]. 2023; doi: 10.5772/intechopen.109967
|
4 |
Toshiyuki Murai, Satoru Matsuda. The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological Diseases. Molecules 2023; 28(5): 2381 doi: 10.3390/molecules28052381
|
5 |
Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, Johann Steiner. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overview. Reviews in the Neurosciences 2023; 34(1): 1 doi: 10.1515/revneuro-2022-0026
|
6 |
Nassima Oumata, Kui Lu, Yuou Teng, Christian Cavé, Yu Peng, Hervé Galons, Bernard P. Roques. Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules. European Journal of Medicinal Chemistry 2022; 240: 114578 doi: 10.1016/j.ejmech.2022.114578
|